Co-Located Conference AgendasDrug Discovery India 2013 | Genomics and Proteomics Research | Microfluidics & Lab on a Chip India | 
Friday, 27 September 201308:00 | Registration | 08:50 | Welcome Address | 09:00 | Address by the Conference Chair | 09:05 |  | Plenary Presentation Inaugural Address
M.N. Vidyashankar, Additional Chief Secretary, Government of Karnatka, India
|
| 09:30 |  | Keynote Presentation Plenary Presentation:Challenges in Drug Discovery - From Natural Products to Designer Molecules
Tushar Chakraborty, Director, Central Drug Research Institute, India
|
| 10:10 | Coffee Break and Networking | |
Session 1: Renaissance in Pharmacognosy I Session Chair: Dr. Krishna Kodukula |
| | 10:30 | Shifting Paradigm for Development of Traditional Medicine – Farm to Pharma
Pulok K Mukherjee, Director- School of Natural Product Studies, Jadavpur University, India
| 10:50 | Advances in Natural Product-based Drug Discovery: Success Story of Swertiamarin
Ramesh Goyal, Distinguished Professor, Ahmedabad University, India
| 11:10 |  | Keynote Presentation Special Lecture: Pharmacognosy: Time to Refresh and Accelerate Drug Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India
|
| 11:30 | Development of Novel Potential Cancer Therapeutics
Paturu Kondaiah, Professor, Indian Institute of Science, India
| |
Session 2: Renaissance in Pharmacognosy II Session Chair: Dr. Kalpana Joshi |
| | 11:50 | Modern Tools to Mine Traditional Medicine
Badireenath Konkimalla, Reader-F, National Institute of Science Education and Research, India
| 12:10 | Drug Discovery from Natural Sources- Pre-clinical to Clinical
Pralhad Patki, Head, The Himalaya Drug, India
| 12:30 | Commercial Use of Endophytic Fungi for Industrial Production of Bioactive Secondary Metabolites
Chelliah Jayabaskaran, Professor, Indian Institute of Science, India
| 12:50 |  Technology Spotlight:
Enabling Drug Discovery for Natural & Synthetic Products: A New Approach
K K Bhagchandani, Director, Advanced Chemistry Development Inc
| 13:05 | Lunch and Networking | |
Session 3: Explorations in Chemical Biology Session Chair: Dr. Dipak Ramji |
| | 14:00 | Atherosclerosis: New perspectives, Therapeutic Strategies and Translational Challenges
Dipak Ramji, Professor, Cardiff University, United Kingdom
| 14:20 | Novel Translational Approach to Neurodegenerative Disease; Peptides Derived from the Activator of Neuronal Cell Cycle like Kinase (Cdk5) Prevented Alzheimer’s Disease (AD) Phenotypes in AD Model Mice.
Harish Pant, Senior Investigator, National Institute of Health, United States of America
| 14:40 | Ascent of Coenzyme Q
T. Ramasarma, Professor, Indian Institute of Science, India
| 15:00 | The Evaluation of the Effect of Fibrinolytic Drugs on the Vasopressin Elicited Phospholipase C Activity in the Goat Kidney
Manoj Tyagi, Professor of Pharmacology, Christian Medical College, India
| |
Session 4: Screening Techniques in Drug Discovery Session Chair: Dr. G.N. Sastry |
| | 15:10 |  | Keynote Presentation New Generation Molecular Descriptors for Accelerating Drug Discovery Process
Anil Madan, Professor, Pandit B D Sharma University of Health Sciences, India
|
| 15:40 | Virtual Screening Techniques in Lead Identification : What to Expect ?
G Sastry, Sr Principal Scientist, Indian Institute of Chemical Technology, India
| 16:00 | Coffee Break and Networking | |
Session 5: Advances in Chemo-and Bio-Informatics Session Chair: Dr. Harish Pant |
| | 16:20 | OpenSource Chemoinformatics Tools and Methods for Virtual Screening
M Karthikeyan, Chemoinformatics Scientist, National Chemical Laboratory, India
| 16:40 | Genomic Approaches to Drug Discovery
Kalpana Joshi, Professor & Head, Sinhgad College of Engineering, India
| 17:00 | ![SelectBio]() Technology Spotlight:
Director, GVK Biosciences
, , SelectBio
| 17:20 |  | Keynote Presentation Envisioning a Path to the Future
Litao Zhang, Vice President/Leads Discovery & Optimization, Bristol-Myers Squibb, United States of America
|
| 18:00 | End of the Day | 18:30 | Drinks Reception and Networking in the Exhibition Area |
Saturday, 28 September 201308:30 |  | Keynote Presentation Plenary Presentation:Alternative Therapies in Cutaneous Leishmaniasis
Walderez Dutra, Professora Titular, Federal University of Minas Gerais, Brazil
|
| |
Session 6: Rare and Neglected Diseases Session Chair: Dr. Swati Joshi |
| | 09:10 |  | Keynote Presentation Anti-Viral Drug Development: Strategies and Challenges
Krishna Banaudha, Associate Professor, The George Washington University, United States of America
|
| 09:30 | Biodiversity, Chemical Diversity and Phytodrugs
Swati Joshi, Scientist F, National Chemical Laboratory, India
| 09:50 | Challenges in Drug Development for Dengue Fever: Immunoregulatory Aspects Associated with Hemorrhagic Manifestations
Kenneth Gollob, Professor, Institute for Education and Research, Brazil
| 10:10 | Repurposing Old Drugs for New Regimens for Tuberculosis
Amit Singhal, Senior Research Scientist, Agency for Science Technology & Research A*Star, Singapore
| 10:20 | Coffee Break and Networking | |
Session 7: Novel Enabling Technologies Session Chair: Dr. Hakim Djaballah |
| | 10:40 |  | Keynote Presentation Cell Based Assays in Drug Discovery: Changing The HTS Paradigm
Hakim Djaballah, CEO, Institute Pasteur - Korea, Korea South
|
| 11:10 | Whole animal HTS: A Novel Antibacterial Drug Discovery Platform
Horst Flotow, Senior Project Manager, D3 (Drug Discovery and Development)e, Singapore
| 11:30 | EU-OPENSCREEN – Building a Pan-European Resource and Infrastructure to Support Chemical Biology Research
Ronald Frank, Coordinator, The Leibniz Institute for Molecular Pharmacology, Germany
| 11:50 |  Technology Spotlight:
Potential of Proteomics and Cellular Analysis in Drug Discovery and Early Toxicology Studies– GE Healthcare Integrated Platforms
Lalith Kishore, General Manager - Research Products, GE Healthcare Lifescience
| |
Session 8: Drug Discovery Research-Trends and Opportunities Session Chair: Dr. Ronald Frank |
| | 12:10 |  | Keynote Presentation Green Nanotechnology Provides Unprecedented Opportunities In Drug Discovery
Kattesh V. Katti, Director, Institute of Green Nanotechnology / Radiology / Cancer Nanotechnology Platform, University of Missouri, United States of America
|
| 12:40 | Novel Enabling Synthetic Strategies: Sustainable Technologies in Academic Drug Discovery Research".
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India
| 13:00 | New Drug Discovery: Challenges and Opportunities-Industry Perspective
Balachandra Bandodkar, General Manager, Alkem Laboratories, China
| 13:20 | Design of Drug Molecules in Reversing Multidrug Resistance in Cancer cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India
| 13:40 | Lunch Break and Networking | 14:40 | Poster Session | |
Session 9: Collaborative Innovation in Biomedicine Session Chair: Dr. John Watson |
| | 15:00 | Drug Discovery, Current and Future Perspectives
D Giles, Professor, Acharya Bm Reddy College of Pharmacy, India
| 15:20 | Importance of Collaboration between Biopharma Industry and Academia for Human Resource Development
Ramesh Sane, Director, Guru Nanak Khalsa college of Art, Science & Commerce, India
| 15:40 | Open Innovation through Industry and Academia collaboration
Manish Diwan, Associate Director, Daiichi Sankyo India Pharma Private Limited, India
| 15:50 | Special Lecture: Non-profit Pharma: A New Paradigm for Innovation
Krishna Kodukula, Executive Director, CADRE, SRI International, United States of America
| 16:10 | Coffee Break and Networking | |
Session 10: Panel Discussion- Current Trends in Contract Research Landscape Session Chair: Dr. M. Bhupathy |
| | 16:30 | Current Trends in Contract Research Landscape
M Bhupathy, Executive Director, Amgen Inc, United States of America
| 16:31 | Current Trends in Contract Research Landscape.
John Watson, Director, Promega Corporation, United States of America
| 16:32 | Current Trends in Contract Research Landscape
Thomas Antony, Research Director, Aurigene Discovery Technologies Limited, India
| 16:33 | Current Trends in Contract Research Landscape
Jayashree Aiyar, VP, Jubliant Biosys, India
| 16:34 | Current Trends in Contract Research Landscape
Sudhir Singh, Senior Vice President, GVK Biosciences Inc, India
| 16:35 | Current Trends in Contract Research Landscape
Manjunath Ramarao, Group Director and Head, Disease Sciences and Technology, Bristol-Myers Squibb India Pvt Ltd, India
| 16:36 | Current Trends in Contract Research Landscape
Manoj Nerurkar, Chief Operating Officer, Syngene International, India
| 17:20 | Poster Award Presentation & Closing Remarks by Conference Chair |
|
Add to Calendar ▼2013-09-27 00:00:002013-09-28 00:00:00Europe/LondonDrug Discovery India 2013Drug Discovery India 2013 in Banglore, IndiaBanglore, IndiaSELECTBIOenquiries@selectbiosciences.com
